Drug / Chemical name: Cabergoline
Adverse Effect / Toxicity: Pericarditis constrictive
Species: Human
Dose: 5 mg/3Y
Dose type: Repeated
Route: Oral
Source link
Source link
Adverse Effect / Toxicity: Pericarditis constrictive
M. Townsend, D.H. MacIver, Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson’s disease, Heart. 90 (2004) e47–e47. doi:10.1136/hrt.2004.036236.